MBIO
NASD Mustang Bio, Inc.$0.4687 ↓ -0.0109 (-2.27%) Trading Down from the previous close of $0.4796, $0.0062 below the day’s high of $0.4749
- YTD change
- -52.22%
- vs 20-day SMA
- -10.38%
- vs 200-day SMA
- -38.77%
Price ranges
Price & Performance
-0.25 (-33.86%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 100.0% away from all-time highs of $10,012.5000
- MBIO is down 52% since the beginning of the year
- MBIO is down 69% over the past 12 months
- MBIO is down 13% over the past 1 month
- 1% of all MBIO investors are betting against MBIO
MBIO reads poor: price sits below both the 20- and 200-day averages, the 12-month move is -68.4%.
- Previous minute
- +$0.0000
- Last hour
- +$0.0090
- Last 5 days
- -11.73%
- vs 8-day SMA
- -9.98%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Mustang Bio, Inc. is a clinical-stage biopharmaceutical company, which engages in the translation of medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline includes CAR T therapies for hematologic malignancies, CAR T therapies for solid tumors, and gene therapies for rare genetic disorders. The company was founded on March 13, 2015 and is headquartered in Waltham, MA.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.
